- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-02-0001808

Layerly Pharmaceuticals Private Limited
About Layerly Pharmaceuticals Private Limited
Data last updated:
Layerly Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2019PTC133555. Its GSTIN is 36AADCL9617J1Z5 (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Udaya Kiran Perla (Managing Director) and Srinivasa Babu Yadala.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at H No: – 8 – 3 – 833/239 P – 2 Sri Rama Nilayam Cellar 101 Kamalapuri Colony, Hyderabad, Telangana, India – 500073.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.68 Cr, a decline of 51% compared to the previous year. For the same year it recorded a net loss of ₹64.23 Lakh (net margin -38.1%) and EBITDA of -₹86.17 Lakh (EBITDA margin -51.2%).
The company has about 2 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Layerly Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0001808).
Company details
Recognitions & Rankings of Layerly Pharmaceuticals
Contact details
Layerly Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH No: – 8 – 3 – 833/239 P – 2 Sri Rama Nilayam Cellar 101 Kamalapuri Colony, Hyderabad, Telangana, India – 500073
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Layerly Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Layerly Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Layerly Pharmaceuticals Private Limited, buy the company report.
Financials of Layerly Pharmaceuticals Private Limited
FY 2022 filings availableLayerly Pharmaceuticals Private Limited reported revenue of ₹1.68 Cr (down 51% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 51% in the latest year. EBITDA rose 9% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹1.68 Cr | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹86.17 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹64.23 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -51.2% | ||
| Net Profit Margin | -38.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Layerly Pharmaceuticals Private Limited, buy the company report.
Board of directors of Layerly Pharmaceuticals Private Limited
Layerly Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Babu Yadala | Director | 20 Jun 2019 | 7 Years 4 Months | Current |
| Udaya Kiran Perla Also directs: Unistar Pharma Private Limited, Unicon Pharma Private Limited, Starus Pharmaceuticals Industries Private Limited and 3 more | Managing Director | 20 Jun 2019 | 7 Years 4 Months | Current |
Auditor
Layerly Pharmaceuticals Private Limited is audited by PRASHANTH & NEERAJ for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRASHANTH & NEERAJ | FY 2022 | 017082S |
Shareholding
The shareholding of Layerly Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Layerly Pharmaceuticals Private Limited, buy the company report.
Legal cases
Layerly Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed against the company by M/S. Suraksha Pharma Pvt. Ltd., Rep. by D. Srinivasa Rao | Pending |
To see the full case history of Layerly Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Layerly Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Layerly Pharmaceuticals Private Limited has a workforce of 2 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Layerly Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCL9617J1Z5 | Telangana | Active | 12 Jul 2019 |
To see the full GST registrations and return filing status of Layerly Pharmaceuticals Private Limited, buy the company report.
Recent activity
Layerly Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Srinivasa Babu Yadala was appointed as Director on 20 Jun 2019.
Frequently asked questions
Layerly Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 June 2019 (7+ years old) and is registered under CIN U24110TG2019PTC133555.
Layerly Pharmaceuticals has 2 current directors:
- Udaya Kiran Perla - Managing Director
- Srinivasa Babu Yadala - Director
The latest financial statements of Layerly Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Layerly Pharmaceuticals is 36AADCL9617J1Z5, registered in Telangana.
The CIN (Corporate Identification Number) of Layerly Pharmaceuticals is U24110TG2019PTC133555. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Layerly Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Layerly Pharmaceuticals was incorporated on 20 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Srinivasa Babu Yadala was appointed as Director on 20 Jun 2019. Udaya Kiran Perla was appointed as Managing Director on 20 Jun 2019.
Yes, Layerly Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0001808).
The registered office of Layerly Pharmaceuticals is at H No: – 8 – 3 – 833239 P – 2 Sri Rama Nilayam Cellar 101 Kamalapuri Colony, Hyderabad, Telangana, India – 500073.